Skip to main content
. 2020 Aug 19;149(2):273–282. doi: 10.1007/s11060-020-03595-5

Table 3.

Crude and age-adjusted incidence rates of brain/CNS tumors by sex, according to histology group, for Georgia, March 1, 2009 to February 29, 2012

Group Specific histology WHO histology code N % CIR AIR (95% CI) Females Males
N % CIR AIR (95% CI) N % CIR AIR (95% CI)
Neuroepithelial tumors 180 12.2 1.35 1.30 (1.12, 1.51) 94 11.7 1.35 1.24 (0.99, 1.52) 84 14.3 1.33 1.34 (1.07, 1.67)
Pilocytic astrocytoma 9421 11 0.7 0.08 0.10 (0.05, 0.17) 5 0.6 0.07 0.08 (0.03, 0.18) 6 1.0 0.09 0.11 (0.04, 0.25)
Diffuse astrocytoma 9400, 9411, 9420 15 1.0 0.11 0.10 (0.06, 0.17) 7 0.9 0.10 0.10 (0.04, 0.20) 8 1.4 0.13 0.12 (0.05, 0.24)
Anaplastic astrocytoma 9401 21 1.4 0.16 0.15 (0.09, 0.23) 11 1.4 0.16 0.15 (0.07, 0.27) 10 1.7 0.16 0.15 (0.07, 0.28)
Glioblastoma 9440, 9441, 9442/3 72 4.9 0.54 0.50 (0.39, 0.63) 35 4.4 0.50 0.42 (0.29, 0.59) 37 6.3 0.59 0.59 (0.42, 0.82)
Other astrocytomas 9380, 9381, 9384, 9424, 9425 2 0.1 0.02 0.01 (0.00, 0.05) 1 0.1 0.01 0.01 (0.00, 0.08) 1 0.2 0.02 0.02 (0.00, 0.10)
Oligodendroglioma 9450 9 0.6 0.07 0.06 (0.03, 0.12) 5 0.6 0.07 0.06 (0.02, 0.14) 4 0.7 0.06 0.06 (0.02, 0.17)
Anaplastic oligodendroglioma 9451 5 0.3 0.04 0.04 (0.01, 0.09) 2 0.2 0.03 0.03 (0.00, 0.11) 3 0.5 0.05 0.05 (0.01, 0.14)
Oligoastrocytoma 9382 21 1.4 0.16 0.15 (0.09, 0.24) 13 1.6 0.19 0.18 (0.09, 0.31) 8 1.4 0.13 0.12 (0.05, 0.25)
Ependymoma 9383, 9391, 9392, 9394 8 0.5 0.06 0.06 (0.02, 0.12) 7 0.9 0.10 0.09 (0.04, 0.19) 1 0.2 0.02 0.02 (0.00, 0.11)
Neuronal—glial 8680, 9390, 9413, 9492, 9493, 9505, 9506 9 0.6 0.07 0.06 (0.03, 0.12) 6 0.7 0.09 0.08 (0.03, 0.18) 1 0.2 0.02 0.01 (0.00, 0.09)
Embryonal—medulloblastoma 9470, 9471, 9473, 9508 7 0.5 0.05 0.06 (0.03, 0.13) 2 0.2 0.03 0.03 (0.00, 0.12) 5 0.9 0.08 0.09 (0.03, 0.21)
Tumors of cranial and spinal nerves Neurinoma 9560 45 3.0 0.34 0.33 (0.24, 0.44) 30 3.7 0.43 0.39 (0.26, 0.56) 14 2.4 0.22 0.24 (0.13, 0.40)
Tumors of meninges 410 27.8 3.05 2.81 (2.54, 3.10) 262 32.6 3.70 3.23 (2.84, 3.66) 125 21.3 1.96 1.92 (1.60, 2.30)
Meningioma 9530, 9531, 9532, 9533, 9534, 9537, 9538, 9539 374 25.3 2.78 2.56 (2.30, 2.84) 243 30.3 3.43 2.97 (2.60, 3.39) 110 18.7 1.73 1.70 (1.39, 2.05)
Mesenchymal—lipoma, haemangioma 8815, 8850, 8861, 9120, 9133, 9150, 9180, 9220, 9364 25 1.7 0.19 0.18 (0.11, 0.26) 14 1.7 0.20 0.19 (0.10, 0.32) 10 1.7 0.16 0.15 (0.07, 0.28)
Haemangioblastoma 9161 11 0.7 0.08 0.08 (0.04, 0.14) 5 0.6 0.07 0.07 (0.02, 0.16) 5 0.9 0.08 0.08 (0.02, 0.19)
Lymphomas Lymphoma 9590, 9680 5 0.3 0.04 0.04 (0.01, 0.09) 3 0.4 0.04 0.04 (0.01, 0.12) 2 0.3 0.03 0.03 (0.00, 0.13)
Germ cell Germinoma 9064, 9080, 9084 4 0.3 0.03 0.03 (0.01, 0.07) 1 0.1 0.01 0.01 (0.00, 0.08) 3 0.5 0.05 0.05 (0.01, 0.15)
Tumors of the sellar region 211 14.3 1.58 1.52 (1.32, 1.75) 125 15.6 1.79 1.73 (1.44, 2.06) 69 11.7 1.08 1.05 (0.82, 1.34)
Pituitary adenoma 8271, 8272 192 13.0 1.44 1.38 (1.19, 1.59) 115 14.3 1.65 1.57 (1.30, 1.89) 61 10.4 0.95 0.93 (0.71, 1.21)
Craniopharyngioma 9350 19 1.3 0.14 0.14 (0.09, 0.22) 10 1.2 0.14 0.15 (0.07, 0.28) 8 1.4 0.13 0.12 (0.05, 0.24)
Unclassified Unclassified 8000 621 42.3 4.66 4.45 (4.10, 4.82) 288 35.9 4.12 3.83 (3.39, 4.31) 291 49.5 4.59 4.56 (4.05, 5.13)
Total 1476 100 11.05 10.48 (9.94, 11.04) 803 100 11.44 10.47 (9.75, 11.24) 588 100 9.26 9.20 (8.47, 9.99)

Age unknown: N = 8

Sex unknown: N = 85

AIR age-adjusted incidence rate per 100,000 person-years (adjusted to the US 2000 standard population), 95% CI 95% confidence intervals (based on the gamma distribution proposed by Tiwari et al. [17]), CIR crude incidence rate